Tafamidis attenuates the decline of cardiac function in patients with transthyretin amyloid cardiomyopathy
1. Patients with transthyretin amyloid cardiomyopathy (ATTR-CM) managed with tafamidis showed decreased worsening in left ventricular (LV) systolic and diastolic ...